A New Anti-arrhythmic Agent Developed

摘要

In cooperation with colleagues from the China Pharmaceutical University over the past 15 years, researchers from the Shanghai Institute of Materia Medica (SIMM), a pharmaceutical research arm of CAS, have developed a new injection of acehytisine hydrochloride as a natural medication against heart rhythm disorders. The drug was officially approved on August 22, 2005 by China's State Food & Drug Administration (SFDA) as a new and marketable pharmaceutical for clinical therapy. The development of the new injection was based on a diterpene alkaloid extracted from Guanbaifuzi (Radix Aconiti Coreani), a herb used by physicians of the Traditional Chinese Medicine for ages. Based on the studies on the extract of effective ingredients from the plant, SIMM scientists discovered a new natural compound that could treat patients with cardiac rhythm disorders.